About Anassa General Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
1
QED Therapeutics, Inc.
1
Clinical Trials at Anassa General Clinic
During the past decade, Anassa General Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations
2020-03-11
2023-01-11
Terminated
39
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
2020-12-07
2028-12-31
Recruiting
550
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Anassa General Clinic"
#1 collaborator was "Helsinn Healthcare SA" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Anassa General Clinic
According to Clinical.Site data, the most researched conditions in "Anassa General Clinic" are
"Upper Tract Urothelial Carcinomas" (1 trials), "Urinary Bladder Neoplasms" (1 trials) and "Urothelial Bladder Cancer" (1 trials). Many other conditions were trialed in "Anassa General Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Anassa General Clinic
Most popular intervention types in "Anassa General Clinic" are "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetrelimab" (1 trials), "Cisplatin" (1 trials), "Conventional radiation therapy" (1 trials), "Gemcitabine" (1 trials) and "Hypo-fractioned radiation therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Anassa General Clinic
The vast majority of trials in "Anassa General Clinic" are
2 trials for "All" genders.
Clinical Trials Status at Anassa General Clinic
Currently, there are NaN active trials in "Anassa General Clinic".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Anassa General Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Anassa General Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".